Sionna therapeutics to present at the goldman sachs 46th annual global healthcare conference

Waltham, mass., june 03, 2025 (globe newswire) -- sionna therapeutics, inc. (nasdaq: sion), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (cf) by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (cftr) protein, today announced that management will participate in a fireside chat at the goldman sachs 46th annual healthcare conference in miami, florida on wednesday, june 11th 2025 at 8:00 a.m.
SION Ratings Summary
SION Quant Ranking